Novo Nordisk Stock Target Price and Analyst Consensus
NVO Stock | USD 126.16 2.48 1.93% |
The current analyst and expert consensus on Novo Nordisk is Buy, with 1 strong sell and 5 strong buy opinions. The current projected Novo Nordisk target price consensus is 80.40 with 11 analyst opinions. The most common way Novo Nordisk AS analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Novo Nordisk executives and customers to further validate their buy or sell advice. Novo Nordisk buy-or-sell recommendation module provides average expert sentiment on the projected Novo Nordisk AS target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Novo Nordisk to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 73.16 | Highest Forecast 89.24 | Target Price 80.4 |
Novo |
It's important to approach Novo Nordisk's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Novo Nordisk price targets
Novo Nordisk's stock target price is an estimate of its future price, usually made by analysts. Using Novo Nordisk's target price to determine if it is a suitable investment can be done through the following steps:- Look at Novo Nordisk's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Novo Nordisk's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Novo Nordisk Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Novo Nordisk is a key component of Novo Nordisk valuation and have some predictive power on the future returns of a Novo Nordisk.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novo Nordisk's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Business Services Invested over 100 shares | ||
Dividend Beast Invested over 60 shares | ||
Macroaxis Index Invested few shares | ||
Investor Favorites Invested over 40 shares | ||
Baby Boomer Prospects Invested over 40 shares | ||
Macroaxis Picks Invested over 40 shares | ||
Driverless Cars Invested few shares | ||
Synthetics Invested over 100 shares | ||
Check out Macroaxis Advice on Novo Nordisk to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Novo Stock analysis
When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
The data published in Novo Nordisk's official financial statements usually reflect Novo Nordisk's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Novo Nordisk AS. For example, before you start analyzing numbers published by Novo accountants, it's critical to develop an understanding of what Novo Nordisk's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Novo Nordisk's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Novo Nordisk's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Novo Nordisk's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Novo Nordisk AS. Please utilize our Beneish M Score to check the likelihood of Novo Nordisk's management manipulating its earnings.